Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • Businesses Solutions • Hardware (& Manufacturing) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Investment Management |
Stages | Startup, Early Stage, Expansion, Later Stage, MBO/LBO |
Investing | United States • France • China • Hong Kong |
Investment Range | €5,000,000 - €1,000,000,000 |
Assets Under Management | €2,800,000,000 |
Cathay Capital Private Equity is a leading international private equity firm established in 2006 with a global investment platform focused on cross-border expansion, digital transformation, and sustainable growth. Based in Paris, France, but with roots in Munich, Germany, their Theatinerstrasse 7 headquarters reflects a commitment to geographical diversity and deep local insights. With assets under management worth over $2.8 billion, they focus on equity investments in a broad range of sectors such as Software, IT and TMT, Media, Business Solutions, Hardware and Manufacturing, HealthTech and Fitness, Blockchain and Cryptos, Logistics and Distribution, Medical Devices and Hospital Services, and Investment Management. The fund's investment strategy is to target small to midsize companies with the potential to become global leaders, generally committing between $5 million to $1 billion per deal. Cathay Capital specializes in Startup, Early Stage, Expansion, and Later Stage investments, as well as management buyouts and leveraged buyouts (MBO/LBO). Their differentiation lies in the Cathay ecosystem, a dynamic network linking investors, startups, established companies, and leading corporations across industries and regions to share knowledge and foster unique business development opportunities, driving industry-wide transformation. Through Cathay INNOVATION, they invest in startups at the forefront of the digital revolution with a positive global impact. In healthcare, Cathay HEALTH invests globally at the convergence of life sciences, healthcare, and tech to improve human health. They endeavor to build responsible, resilient, and sustainable businesses and have a strong emphasis on impact and sustainability, as evidenced by their investments and foundations. The firm has made over 160 investments in the last 17 years across vivid market sectors and has a significant presence with employees globally, operating several funds, and nurturing an extensive portfolio that helps founders and management teams lead markets.